Company Performance Metrics
- Shimon Lecht: Chief R&D Officer
- William Z. Levine: Founder and Chief Scientific Officer
CannRx is a transformative technology company that develops proprietary science-based cannabis technologies. The company also delivers more effective, higher bioavailability, scientifically formulated cannabis products. It specializes in sleep and pain research, as well as on developing products for oncology support, Parkinson's disease,
women's health, and recreational products for the sports industry.
CannRx 's ican.sleep is a proprietary formulation that targets sleep disorders. The product has undergone extensive in-vivo trials in predictive pharmaceutical models. The company's Vapor Capture Technology is an extraction technology designed specifically for the cannabis plant. The commercialized product provides a pre-activated, highly bio-available cannabis extract with a unique cannabinoid/terpene profile.
CannRx is also creating a patented nanoparticle technology to solubilize cannabinoids and terpenes. The process inserts the important cannabis compounds into everyday proteins, resulting in highly soluble and stable nanoparticles.
